Medicine
Hextend 30 g/500 mL injection
Hextend 30 g/500 mL injection is a prescription medicine containing Hetastarch for intravenous use, marketed by Hospira, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. It is recommended that the product be stored at room…
Key facts
- Active ingredient (INN)
- Hetastarch
- Brand
- Hextend
- Strength
- 30 g/500 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 12 bags of 500 mL
- Marketing authorisation holder
- Hospira
- Manufacturer
- Hospira
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. It is recommended that the product be stored at room temperature (25°C/77°F), however, brief exposure up to 40°C does not adversely affect the product.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B05AA07 Hetastarch
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 February 2005
- Identifiers
- RxCUI 310757, 404665DailyMed set ID fc79700c-6c3b-4998-8307-4dc8c81c5041NDC 0409-1555Application BN200952
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 bag in 1 case / 500 mL in 1 bag | 0409-1555-54 | Hospira | 2 February 2005 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Hetastarch 30 g/500 mL injection.
Clinical summary
Hetastarch is a plasma volume expander indicated in the treatment of hypovolemia when plasma volume expansion is desired in settings where adequate alternative treatment is unavailable. It is available as injection for intravenous use. MedsAcross supplies Hetastarch for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HetastarchFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Hextend prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need Hextend 30 g/500 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.